LanthaScreen™ TR-FRET ER alpha Coactivator Assay Kit
LanthaScreen™ TR-FRET ER alpha Coactivator Assay Kit
Thermo Scientific™

LanthaScreen™ TR-FRET ER alpha Coactivator Assay Kit

LanthaScreen™ TR-FRET ER α コアクチベータアッセイキットは、潜在的なエストロゲン受容体( ER) α詳細を見る
製品番号(カタログ番号)数量
A15885800 x 20 μL assays
製品番号(カタログ番号) A15885
価格(JPY)
172,800
Online offer
Ends: 27-Mar-2026
288,000
割引額 115,200 (40%)
Each
お問い合わせください ›
数量:
800 x 20 μL assays
LanthaScreen™ TR-FRET ER α コアクチベータアッセイキットは、潜在的なエストロゲン受容体( ER) α リガンドのアゴニストまたはリガンド依存性コアクチベーターのリクルートのアンタゴニストとしてのハイスループットスクリーニングを行うための高感度で堅牢な方法を提供します。このキットは、グルタチオン S- トランスフェラーゼ(GST)、テルビウム(Tb)標識抗 GST 抗体、およびフルオレセイン標識コアクチベータペプチドでタグ付けされた ER α リガンド結合ドメイン(ER α -LBD)を均質なミックス & リードアッセイフォーマットで使用します。

アゴニスト モード
LanthaScreen TR-FRET ER α コアクチベーターアッセイをアゴニストモード(アゴニスト化合物を同定するため)で実行するために、ER α -LBD をリガンド試験化合物に追加した後、フルオレセインコアクチベーターペプチドと Tb- 抗 GST 抗体の混合物を加えます。室温でインキュベーションした後、TR-FRET 520:495 nm 発光比を計算し、化合物の線量反応曲線から EC50 を決定するために使用します。ER α コアクチベータペプチド相互作用の生物学に基づくこのリガンド EC50 は、受容体への結合、配座変化の影響、およびコアクチベータペプチドのリクルートに必要なリガンドの量を表す複合値です。

アンタゴニストモード
アンタゴニストモードで LanthaScreen TR-FRET ER α コアクチベーターアッセイを実行するには(アンタゴニスト化合物を同定するため)、ER α -LBD をリガンド試験化合物に加え、アゴニスト、フルオレセインコアクチベータペプチド、およびテルビウム(Tb)標識抗抗体を加えます。このモードで使用されるアゴニストの濃度は、最初にアゴニストモードでアッセイを実行することで決定されるEC80濃度です。
研究用途にのみご使用ください。診断目的には使用できません。
仕様
使用対象(アプリケーション)コファクター相互作用アッセイ、核内受容体アッセイ
製品ラインLanthaScreen
数量800 x 20 μL assays
タイプTR-FRET ER alpha Coactivator Assay Kit
Unit SizeEach
組成および保存条件
1 チューブ ER α リガンド結合ドメイン組み換えタンパク質(-68~-85℃で保存)
ペプチド 1 本(-5~-30℃で保存)
2 本のボトル TR-FRET バッファー(-5~-30℃で保存)
1 チューブ Tb-Anti-GST Ab(-5~-30℃で保存)
DTT のチューブ 1 本(-5~-30℃で保管)

よくあるご質問(FAQ)

I'm using the TaqMan hPSC Scorecard Panel. How many genes are tested per sample?

93 genes are tested per sample. There are 9 self-renewal genes, 74 lineage specific genes, and 10 housekeeping and control genes.

Find additional tips, troubleshooting help, and resources within our Real-Time PCR and Digital PCR Applications Support Center

How does the LanthaScreen technology compare to other TR-FRET assay formats?

We performed a comparison between the LanthaScreen assay and other commercially available TR-FRET assays from 2 different suppliers for the PKC kinase target. Our data revealed that the assays performed comparably, but that the LanthaScreen assay was simpler to optimize and contained fewer components that required optimization. The LanthaScreen assay is a two component system, whereas the other assay formats utilize a trimolecular mechanism which is more time consuming to optimize and has added costs.

For my kinase assay, can I pre-mix the Tb-Ab and EDTA so that I can stop the kinase assay and begin detection with a single reagent addition?

Yes, this is possible depending on the concentrations of reagents used and the time for which they are mixed. We recommend developing and optimizing the assay by using separate reagent additions, because this method will work under the widest range of conditions. Once the assay is optimized, the performance of the assay using pre-mixed antibody and EDTA can be evaluated. We have successfully developed robust assays in which the antibody and EDTA were pre-mixed and then stored overnight at 4 degrees C prior to use the following day. A loss of signal intensity was observed in this case, however, by using the ratiometric readout, this effect was minimal.

Are the LanthaScreen reagents stable to interference from Mg2+, Mn2+, and EDTA?

The chelate is completely stable to Mg2+. The amount of Mn2+ or EDTA that the chelate can tolerate depends largely on how long they are mixed together and the combination of additives used in the reaction. If a reaction requires either Mg2+ or Mn2+ for activation, it is best to stop the reaction by adding an equimolar amount (or slight excess) of EDTA to chelate the metal ions present. This will then essentially eliminate any interference on the terbium chelate by EDTA or Mn2+. Regardless, when LanthaScreen assays are performed using a ratiometric readout (division of the acceptor signal by the donor signal), any interference caused by Mn2+ or EDTA is largely cancelled out.

What is the optimal and/or maximum distance for a Tb-fluorescein pair?

The Förster radius, the distance at which energy transfer efficiency is half-maximal, is around 50-angstroms for the terbiumÆ fluorescein pair. However, the Förster radius does not give a complete indication of energy transfer efficiency when using long lifetime fluorophores such as terbium chelates. When using terbium chelates, energy transfer efficiency is determined by the distance of closest approach between the donor and acceptor during the excited state lifetime of the donor. In many assay systems, such as those designed using antibodies or peptides, there is a large degree of conformational freedom that allows the donor and acceptor to approach one another, effectively enhancing the FRET signal. Additionally, it is important to note that as the donor/acceptor pair approach one another and the efficiency of energy transfer increases, the fluorescent lifetime decreases to a comparable extent. From a practical standpoint, this means that when energy transfer is extremely efficient, FRET cannot be measured in time-resolved mode (because the energy transfer is complete before the measurement is made). This is another reason why TR-FRET assays based around terbium-labeled antibodies or streptavidin perform so well, because there exist a range of donor/acceptor distances, several of which are optimal for measuring FRET.